Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber
Clinical trial NCT01222299 · COMPLETED
Trial details
- NCT number
- NCT01222299
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-08-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.